INSTRUCTIONS FOR AUTHORS

In order to achieve uniform presentation and to avoid unnecessary delays, all authors are requested to follow the next guidelines.

Pentru a evita intarzieri nedorite in publicarea articolelor, autorii sunt rugati sa respecte urmatoarele recomandari.

  • FARMACIA publishes original papers in English. The following fields are covered: pharmaceutical and medicinal chemistry, biochemistry, biopharmacy, pharmaceutical analysis and drug control, pharmaceutical technology, experimental and clinical pharmacology, pharmaceutical biology, history of pharmacy
    • Articles are considered for publication depending on: scientific value, originality of the research and the manuscript submission date
    • The manuscript is only accepted if neither the article nor any essential part of this has been published previously and is submitted exclusively to the journal FARMACIA. A separate covering letter signed by all the authors must state that authors agreed with the submission and that the material is no under the consideration for publication elsewhere. The declaration must contain, also, a statement that all procedures and experimental protocols are in compliance with the Directive 2010/63/EU of the European Parliament and of the Council of the European Union. It will also be indicated the name, address, phone number and e-mail address or fax of the corresponding author.
    • Starting from February 2021, the manuscript will be submitted via the online system implemented on our new website: www.farmaciajournal.com
    • The rejected articles will not be returned to the authors
    • The paper should be structured as follows:
    - Title. The article title should be precise and representative and must be drawn up both in Romanian and English (if none of the authors is Romanian, the editorial team can provide a translation for the title and abstract)
    - The full name of all authors: first name, surname. If there are several authors affiliated to different institutions arabic numerals will be used as superscripts to indicate this
    - Names and the address of the institutions where the work was done
    - The e-mail address of the author for correspondence
    - Abstract (not exceeding 900 characters) and 3-4 keywords; both must be written in Romanian and English
    - The paper will be written in a clear and accurate manner and must be organized in the following format: Introduction/Background. A brief interpretation of the literature considering the current state of the knowledge in the field; Materials and Methods. Will include the presentation of utilized methods and materials; Results and Discussion. Iconography. Each table should have a brief, specific, descriptive title. Number all tables using Romanic numerals. The diagrams, graphics and photographs, named “figures” will have arabic numbers, and should have a descriptive title. Manuscripts containing figures of insufficient quality cannot be accepted. Color illustrations are accepted only if they are essential. Conclusions. Should state the conclusions drawn from the results; - References. Please use numbers in square parentheses to indicate the use of references in the body of the manuscript. The bibliography will be ordered alphabetically, and will contain: the surname and the initials of the name of the authors, the title, journal name, year, volume and page numbers; the paper must contain recently published papers; the references of books will contain: the surname and the initials of the name of the authors, the title of the book, the publishing house, the city where it was published, the year and the page or the pages of the reference
    • Abbreviations should be defined at the first mention and thereafter applied consistently throughout the article. The abbreviations and the measuring unites will be used in agreement with the valid standards
    • Do not use footnotes

  • The authors should ensure research involving human subjects complies with the Declaration of Helsinky and should include in the manuscript that the subjects have given their informed, written consent. Research involving animals should comply with the Universities Federation for Animal Welfare guidelines.
    The authors have to sign this Conflict of interest disclosure form.
  • Published Conflict-of-Interest Statement
    Public trust in the peer review process and the credibility of published articles depend in part on how well conflict of interest is handled during writing, peer review, and editorial decision making. Conflict of interest exists when an author (or the author's institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from those with negligible potential to those with great potential to influence judgment, and not all relationships represent true conflict of interest. The potential for conflict of interest can exist whether or not an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion.

          - International Committee of Medical Journal Editors ("Uniform Requirements for Manuscripts Submitted to Biomedical Journals") -- February 2006

  • Published Statement of Informed Consent

    Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance.

    Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.

    The requirement for informed consent should be included in the journal's instructions for authors. When informed consent has been obtained it should be indicated in the published article.

          - International Committee of Medical Journal Editors ("Uniform Requirements for Manuscripts Submitted to Biomedical Journals") -- February 2006

  • Published Statement of Human and Animal Rights

    When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

          - International Committee of Medical Journal Editors ("Uniform Requirements for Manuscripts Submitted to Biomedical Journals") -- February 2006

  • Starting with issue 3/2018 FARMACIA Journal, all published articles will be charged with a fee of 160 EUR (or 175 USD) / published article

    The decision of the Editorial Board to introduce a publishing fee was approved by the General Assembly of the Romanian Society for Pharmaceutical Sciences (SSFR), on 17th April 2015.

  • The amount of 160 EUR will be deposited in the following account:
    RO35BRDE410SV06100414100 - BRD Bank, Bucharest, Romania
    Swift code: BRDEROBU
    Account name: Societatea de Stiinte Farmaceutice din Romania,
    Mentioning:  "Farmacia article fee" + the name of the author for correspondence.

  • The amount of 175 USD will be deposited in the following account:
    RO08BRDE410SV24737564100 - BRD Bank, Bucharest, Romania
    Swift code: BRDEROBU
    Account name: Societatea de Stiinte Farmaceutice din Romania,
    Mentioning:  "Farmacia article fee" + the name of the author for correspondence.

  • ***
  • RUGAM AUTORII ROMANI SA NU TRANSFERE TAXA DE PUBLICARE IN CONTURILE IN EURO SAU DOLARI MENTIONATE MAI SUS. VA RUGAM SA TRANSFERATI TAXA IN LEI, IN CONTURILE PE CARE LE PUTETI GASI MAI JOS, LA FINALUL INSTRUCTIUNILOR IN LIMBA ROMANA.

  • ***
    Revista FARMACIA publica lucrari originale in limba engleza, din urmatoarele domenii: chimia medicamentului, biochimie, biofarmacie, analiza si controlul medicamentului, tehnica farmaceutica, farmacologie, botanica farmaceutica, istoria farmaciei.
    • Ordinea publicarii articolelor este determinata de valoarea stiintifica si originalitatea lucrarilor, precum si de data intrarii in redactie a manuscrisului.
    • Lucrarea este acceptata numai daca nu a fost publicata, integral sau partial, in alte reviste de specialitate si este depusa exclusiv la revista FARMACIA. Lucrarea trebuie insotita de o declaratie, semnata de toti autorii, care trebuie sa certifice ca acestia sunt de acord cu publicarea si ca materialul nu este depus spre publicare la o alta revista. Declaratia trebuie sa mentioneze, de asemenea, ca toate procedurile si protocoalele experimentale utilizate sunt in concordanta cu Directiva Parlamentului European si a Consiliului Uniunii Europene 2010/63/EU. Manuscrisul trebuie sa contina numele, adresa, numarul de telefon si adresa de e-mail sau fax, a persoanei de contact.
    • Incepand din februarie 2021, manuscrisul va fi trimis prin intermediul sistemului online de pe site-ul nou al revistei: www.farmaciajournal.com
    Articolul va fi scris in format WORD, nearhivat, cu font Times New Roman, dimensiunea literei 14, la 2 randuri, cu margini libere 2cm. Se recomanda ca lucrarea sa nu depaseasca 10 pagini. Nu adaugati numare de pagina si nu introduceti text in antet sau in subsol. Nu se accepta corecturi de mana.
    • Articolele respinse nu vor fi returnate autorilor
    • Se recomanda insistent ca lucrarea sa fie structurata astfel:
    - Titlul: Acesta trebuie sa fie concret si complet; din el sa reiasa exact continutul lucrarii; titlul trebuie sa fie in limba romana si engleza.
    - Numele autorilor: prenumele complet si numele. Daca exista mai multi autori afiliati la diverse institutii, se vor utiliza numere arabe ca superscript pentru precizare.
    - Numele si adresa institutiilor unde s-a efectuat lucrarea
    - Adresa de e-mail a autorului pentru corespondenta
    - Rezumatul (nu mai mult de 900 caractere) si 3-4 cuvinte cheie trebuie scrise in limba romana si in limba engleza.
    - Lucrarea va fi redactata clar si trebuie structurata astfel: Introducere. O scurta prezentare a datelor din literatura privind stadiul actual al cunoasterii in domeniu; Materiale si Metode.
    Include prezentarea materialelor si metodelor utilizate in articol. Rezultate si discutii.
    Iconografia. Fiecare tabel va avea un titlu scurt, descriptiv. Numerotarea tabelelor se va face cu cifre romane. Diagramele, graficele si fotografiile, numite figuri vor fi numerotate cu cifre arabe si vor avea un titlu scurt, descriptiv. Manuscrisele care contin figuri neclare nu vor fi acceptate. Figurile color vor fi acceptate numai daca sunt esentiale in prezentarea lucrarii.
    Concluzii. Trebuie sa contina strict concluziile care reies din rezultate. Bibliografie. Indicatiile bibliografice vor fi ordonate alfabetic si notate in text prin cifre scris intre paranteze patrate; articolele citate vor contine: numele si initiala prenumelui autorilor, titlul articolului, titlul revistei, anul, volumul, paginile (prima si ultima); lucrarea trebuie sa contina bibliografie recenta. Citarea cartilor va contine: numele si initiala prenumelui autorilor, titlul cartii, editura, localitatea unde a fost editata cartea, anul aparitiei, pagina sau paginile la care se face referire
    • Abrevierile trebuie definite la prima aparitie in text si utilizate consecvent ulterior. Abrevierile si unitatile de masura se vor utiliza in concordanta cu standardele in vigoare
    • Nu utilizati note de subsol


    Incepand cu numarul 3/2015, Revista FARMACIA percepe taxa pentru publicarea articolelor.

    Aceasta propunere a Colegiului de Redactie a fost aprobata in cadrul Adunarii Generale a Societatii de Stiinte Farmaceutice din Romania(SSFR), in data de 17 aprilie 2015.

    Incepand cu numarul 3/2018, taxe de publicare a fost stabilita la suma de 750 Ron/articol publicat.

    Sunt exceptate de la plata taxei, articolele ale caror autori SUNT TOTI MEMBRI SSFR SI ABONATI AI REVISTEI FARMACIA (in acest caz, trebuie trimise actele doveditoare, scanate, pe adresa de email ssfr@revistafarmacia.ro).

    Suma de 750 lei se depune in contul:
    RO55BRDE410SV52930644100 - BRD, Bucuresti
    Numele Contului: Societatea de Stiinte Farmaceutice din România
    cu mentiunea: "Taxa articol FARMACIA" si NUMELE AUTORULUI DE CORESPONDENTA.

    ***